What is the treatment for conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Conjunctivitis

Treatment of conjunctivitis must be tailored to the specific etiology: viral conjunctivitis requires only supportive care, bacterial conjunctivitis benefits from topical antibiotics in moderate-to-severe cases, and allergic conjunctivitis responds best to topical antihistamines with mast cell-stabilizing properties. 1, 2

Initial Classification Algorithm

First, determine the type of conjunctivitis based on clinical presentation:

  • Bacterial conjunctivitis: Look for yellow crusting around the eyes, mucopurulent discharge, matted eyelids upon waking, and absence of itching 3, 4
  • Viral conjunctivitis: Typically presents with watery discharge, often bilateral involvement, and variable signs at presentation 2, 5
  • Allergic conjunctivitis: Distinguished by severe itching (the most consistent sign), watery discharge, and history of allergen exposure 4, 6

Treatment by Type

Viral Conjunctivitis

  • Supportive care only - no antibiotics needed as this is self-limited 2, 5
  • Use artificial tears, cold compresses, and antihistamine eye drops for symptom relief 5
  • Avoid topical corticosteroids - they prolong adenoviral infections and worsen HSV infections 1, 2
  • Instruct patients to return only if symptoms persist beyond 2-3 weeks 2, 3
  • Emphasize strict hand hygiene to prevent transmission 5

Special case - HSV conjunctivitis: If dendritic lesions are present, treat with ganciclovir 0.15% gel three to five times daily or trifluridine 1% solution five to eight times daily 2. Oral alternatives include acyclovir 200-400 mg five times daily, valacyclovir 500 mg two to three times daily, or famciclovir 250 mg twice daily 2. Follow up within 1 week 2.

Bacterial Conjunctivitis

Mild cases: Self-limited and resolve spontaneously in 1-2 weeks without treatment in immunocompetent adults 2, 3, 4

Moderate-to-severe cases:

  • Prescribe a 5-7 day course of broad-spectrum topical antibiotics 2, 3
  • Topical antibiotics decrease duration and allow earlier return to school/work 4
  • Clean eyelids and lashes with warm water and gentle soap to remove crusts before applying medication 3
  • Patients must return if no improvement after 3-4 days 1, 2, 3

Alternative when antibiotics unavailable: Povidone-iodine 1.25% ophthalmic solution may be as effective as topical antibiotics 2

Gonococcal Conjunctivitis

  • Requires systemic antibiotics - topical treatment alone is insufficient 1, 2, 3
  • Saline lavage promotes comfort and faster resolution 2, 3
  • Daily follow-up is mandatory until complete resolution 1, 2, 3
  • Treat sexual contacts concurrently and inform them about possible concomitant disease 1, 2, 3
  • Hospitalization may be necessary for severe cases and is mandatory for neonatal conjunctivitis 1, 2, 3

Chlamydial Conjunctivitis

  • Systemic antibiotic therapy is required - more than 50% of infants have infection at other sites 1, 2, 3
  • Treat sexual contacts concurrently 1, 2, 3
  • Re-evaluate following treatment due to potential treatment failure (up to 19%) 2, 3
  • In resource-limited settings, povidone-iodine 1.25% ophthalmic solution can be used 1, 2
  • Consider sexual abuse in children with gonococcal or chlamydial infections 2

Allergic Conjunctivitis

First-line simple measures:

  • Wear sunglasses as barriers to airborne allergens 1, 2, 3
  • Apply cold compresses and refrigerated artificial tears 1, 2, 3

Pharmacologic treatment algorithm:

  • Mild cases: Over-the-counter topical antihistamine/vasoconstrictor agents or second-generation topical H1-receptor antagonists 2
  • Moderate cases (first-line): Topical antihistamines with mast cell-stabilizing properties are the treatment of choice for both acute and chronic disease 1, 2, 3
  • Persistent/recurrent cases: Mast cell stabilizers like cromolyn sodium 2, 3
  • Severe cases: Add a brief course (1-2 weeks) of topical corticosteroids with low side-effect profile 1, 2, 3

Contact Lens-Related Conjunctivitis

  • Discontinue contact lens wear immediately until the cornea returns to normal 3
  • Consider a brief (1-2 weeks) course of topical corticosteroids plus longer-term topical cyclosporine 0.05% 3
  • For giant papillary conjunctivitis: replace lenses more frequently, decrease wearing time, use preservative-free lens care systems, or switch to daily disposable lenses 3

Corticosteroid Monitoring (When Used)

  • Monitor intraocular pressure (IOP) periodically and perform pupillary dilation to evaluate for glaucoma and cataract 2, 3
  • Taper corticosteroids once inflammation is controlled 2, 3
  • Prefer corticosteroids with poor ocular penetration (fluorometholone) or site-specific agents (rimexolone, loteprednol) to reduce risk of elevated IOP or cataract formation 2, 3

Immediate Ophthalmology Referral Criteria

Refer immediately for any of the following 1, 2, 3:

  • Visual loss
  • Moderate or severe pain
  • Severe purulent discharge
  • Corneal involvement
  • Conjunctival scarring
  • Lack of response to therapy
  • Recurrent episodes
  • History of HSV eye disease
  • History of immunocompromise

Critical Pitfalls to Avoid

  • Never use topical antibiotics or corticosteroids indiscriminately - they induce toxicity, prolong adenoviral infections, and worsen HSV infections 1, 2, 3
  • Chronic vasoconstrictor use causes rebound vasodilation upon discontinuation 2, 3
  • Oral antihistamines may worsen dry eye syndrome and impair the tear film's protective barrier 2, 3
  • Topical trifluridine causes inevitable epithelial toxicity if used beyond 2 weeks; topical ganciclovir is less toxic 2
  • Always identify and treat sexual contacts in sexually transmitted conjunctivitis 1, 2, 3
  • Never share towels, pillows, or cosmetics to prevent transmission 1

References

Guideline

Treatment of Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Conjunctivitis: Diagnosis and Management.

American family physician, 2024

Research

Conjunctivitis.

American family physician, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.